Biology is about growth. This applies to the science and it applies to life-science ventures. And if, like cells and many plant and animal species, these ventures grow by doubling, all the better.
What we do
We build non-traditional life-science companies in non-traditional ways.
Biotech ventures are a major source for novel therapeutics. There have been, will continue to be, many successes. And the business model (so long as the underlying biology works) is well established. We are involved in a few such ventures ourselves.
But our heart lies on the road less travelled. Where are the opportunities outside core therapeutics? What are the most robust business models for such businesses? How can life-science ventures best play a wider role in meeting the challenges of the modern world?
